Molecular diagnostics startup Metamark Genetics Inc. has named Mark Straley as the company’s new president, CEO and member of the board of directors. Interim CEO Kenneth Weg, a co-founder of the company, will continue in his role as chairman of the board.
Straley’s experience in diagnostics and diabetes stems from a previous role as worldwide president of Johnson & Johnson’s Diagnostics division, where he began working in 2005 as vice president of marketing. He gained prior management, sales and marketing experience at Bayer Healthcare and Abbott Laboratories. Straley earned a bachelor’s degree from Miami University of Ohio.